Nachrichten zu Royalty Pharma Registered (A)

Startseite > Aktien > Royalty Pharma Registered (A) > Nachrichten

Royalty Pharma Registered (A) Aktie

Aktie

ISIN: GB00BMVP7Y09 WKN: A2P62D Land Flagge GB

Großbritannien

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

25,13

EUR

-1,28 %

-0,33 EUR

Letzter Kurs 19.09.24 Lang & Schwarz

Geldkurs

19.09.24

24,950

EUR

198 STK

Briefkurs

19.09.24

25,30

EUR

198 STK

Royalty Pharma Registered (A) Aktie kaufen

Kauf

Verkauf

Sparplan anlegen

Neueste Nachrichten

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement 03.09.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference 28.08.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma Reports Second Quarter 2024 Results 08.08.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital 24.07.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024 19.07.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma Declares Third Quarter 2024 Dividend 17.07.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference 04.06.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes 03.06.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million 28.05.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline 22.05.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma to Present at Upcoming Investor Conferences 13.05.24 · globenewswire · Royalty Pharma Registered (A)
Royalty Pharma Reports First Quarter 2024 Results 09.05.24 · globenewswire · Royalty Pharma Registered (A)

1
2
…
3

Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement 832 Leser
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference 500 Leser

wO Börsenlounge: Apple \| Tesla \| Adidas - Startschuss für Cannabis-Aktien gefallen? 11664 Leser
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement 832 Leser
Fokus Aktien mit extremen Handelsvolumen am Freitag, den 12.01.2024 796 Leser
Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference 500 Leser
Royalty Pharma Reports First Quarter 2024 Results 492 Leser
Royalty Pharma Reports Second Quarter 2024 Results 356 Leser
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million 320 Leser
Royalty Pharma Reports Third Quarter 2023 Results 228 Leser
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to ... 228 Leser
Royalty Pharma Appoints Eric Schneider as Chief Technology Officer 192 Leser